EVFM News and Press, Evofem Biosciences Inc. From 09/19/22

Inventor of the Year Awarded to Developer of Phexxi® PR Newswire -- Dr. Donald Waller Honored by University of Illinois Chicago -- SAN DIEGO , Sept. 19, 2022 /PRNewswire/ -- Evofem Biosciences (OTCPK: EVFM) is plea...

Large Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide PR Newswire -- One of the Largest Commercial Payers in the U.S. Expands Access to Phexxi ® for Women Seeking FDA-Approved, Hormone-Free Contraception -- SAN DIEGO , ...

Evofem Biosciences, Inc. ( OTC:EVFM ), a biopharma focused on women's sexual and reproductive health, announced on Friday that the company concluded a successful debt restructuring process, giving creditors the rights to acquire its common stock. The restructuring has provided...

Evofem Announces Successful Debt Restructuring PR Newswire -- Evofem Gains Forbearance from Debtholders for All Existing Matters-- SAN DIEGO , Sept. 16, 2022 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCPK: EVFM) today announced the succe...

Summary An excessive rate of spending has put the company in a terrible financial position. Phexxi is a product with a suboptimal profile, and sales figures support this conclusion. A new indication in STI prevention is not likely to generate significant sales. Insig...

Evofem Biosciences to Host Investor Call on Thursday, August 11, 2022 PR Newswire -- Conference Call Scheduled for 5:00 p.m. ET -- SAN DIEGO , Aug. 10, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (EVFM) will hold an investor call as fol...

NEW YORK, NY / ACCESSWIRE / August 9, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with Evofem Biosciences. Mark Roberts, Senior Editor at Traders New...

Buying Penny Stocks on August 5th? Here’s What You Need to Know With another week of trading penny stocks coming to an end, there is a lot that investors need to know. Already in August, we have seen a major amount of movement across the board with both penny stocks and blue ch...

Evofem Biosciences, Inc. (EVFM) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Amy Raskopf - Vice President-Investor Relations Saundra Pelletier - Chief Executive Officer, President and Executive Director Jay File - Chief Financia...

Evofem Biosciences ( NASDAQ: EVFM ) stock soared ~31% post market on Aug. 4 after Q2 net loss narrowed and the women health company reaffirmed its FY22 product sales outlook. Q2 net sales of birth control vaginal gel Phexxi grew +42% Q/Q to $6M. The com...